Race and ethnicity do not impact eligibility for remdesivir: A single-center experience

As the Coronavirus-2019 (COVID-19) pandemic continues, multiple therapies are rapidly being evaluated for efficacy in clinical trials. Clinical trials should be racially and ethnically representative of the population that will eventually benefit from these medications. There are multiple potential...

Descripción completa

Detalles Bibliográficos
Autores principales: Pischel, Lauren, Walelo, Makeda, Benson, Jemma, Osborn, Rebecca, Schrier, Rachel, Tuan, Jessica, Barakat, Lydia, Ogbuagu, Onyema
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101938/
https://www.ncbi.nlm.nih.gov/pubmed/33956849
http://dx.doi.org/10.1371/journal.pone.0250735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101938/
https://www.ncbi.nlm.nih.gov/pubmed/33956849
http://dx.doi.org/10.1371/journal.pone.0250735

Ejemplares similares